[1] Muloiwa R, Kagina BM, Engel ME, Hussey GD. The burden of pertussis in low-and middle-income countries since the inception of the Expanded Programme on Immunization (EPI) in 1974: a systematic review protocol. Systematic reviews. 2015 Dec;4(1):62.
[2] World Health Organization. Pertussis vaccines: WHO position paper – August 2015. Wkly Epidemiol Rec. 2015;90(35):433–60.
[3] Yeung KH, Duclos P, Nelson EA, Hutubessy RC. An update of the global burden of pertussis in children younger than 5 years: a modelling study. The Lancet Infectious Diseases. 2017 Sep 1;17(9):974-80.
[4] Faulkner A, Skoff TH, Martin SW, Cassiday PK, Tondella ML, Liang JL. Manual for the surveillance of vaccine-preventable diseases. Chapter 10: Pertussis; 2015.
[5] World Health Organization. Surveillance standards for vaccine-preventable diseases. Geneva: World Health Organization; 2018.
[6] World Health Organization. Vaccine-Preventable Diseases (Pertussis) Surveillance Standards, Pertussis Geneva: World Health Organization; 2018.
https://www.who.int/immunization/monitoring_surveillance/burden/vpd/WHO_SurveillanceVaccinePreventable_16_Pertussis_BW_R2.pdf?ua=1 (accessed on 21 May 2019)
[7] Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. Washington DC Public Health Foundation. 2015;2:20-.
[8] Wiley KE, Zuo Y, Macartney KK, McIntyre PB. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine. 2013 Jan 11;31(4):618-25.
[9] Roush RW, Murphy TV, Are V. TV, Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. InJama 2007.
[10] Centers for Disease Control and Prevention. In Prevention: vaccine. USA; 2017. https://www.cdc.gov/pertussis/about/prevention/index.html (accessed on 21 May 2019).
[11] Miller E, Siegrist C, Tharmaphornpilas P. WHO SAGE pertussis working group Background paper SAGE April 2014.
[12] Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis?. The Lancet infectious diseases. 2003 Jul 1;3(7):413-8.
[13] World Health Organization. SAGE pertussis working group background paper. In World Health Organization, Geneva, Switzerland
https://www.who.int/immunization/sage/meetings/2014/april/1_Pertussis_background_FINAL4_web.pdf (accessed on 21 May 2019).
[14] Federal Ministry of Health (FMOH). Comprehensive Multiyear Plan 2016–2020. Ethiopia National Expanded Programme on Immunization. Addis Ababa: Federal Ministry of Health; 2015.
[15] World Health Organization. Immunization monitoring global summary. Geneva: World Health Organization. http://apps.who.int/immunization_monitoring/globalsummary/countries?countrycriteria%5Bcountry%5D%5B%5D=ETH&commit=OK Error! Hyperlink reference not valid. (Accessed 21 May 2019)
[16] Central Statistical Agency (CSA) and ORC Macro Inc. Ethiopia Demographic and Health Survey 2016. Addis Ababa, Ethiopia and Calverton, Maryland: USACSA and ORC Macro; 2016.
[17] Dara Malo District Health Office. Annual Public Health Emergency Management Report of Dara Malo District . Wacha Town: Dara Malo District Health Office; 2019.
[18] Bloom DE, Cadarette D. Infectious Disease Threats in the 21st Century: Strengthening the Global Response. Frontiers in immunology. 2019;10:549. doi:10.3389/fimmu.2019.00549
[19] Alamaw SD, Kassa AW, Gelaw YA. Pertussis outbreak investigation of Mekdela district, South Wollo zone, Amhara region, North-West Ethiopia. BMC research notes. 2017 Dec;10(1):420.
[20] Tesfa, F. 2018. Outbreak Investigation, Pertussis outbreak investigation of Abergelle district, Wag Himra zone, Amhara region, North - East Ethiopia in Compiled Body of Works in Field Epidemiology. Addis Ababa University (unpublished Thesis for Master of Public Health in Field Epidemiology).
[210] Kansas Department of Environment & Health. (2012). Pertussis (Whooping Cough) Investigation Guideline. Topeka: KDHE.
[22] SPSS, Inc. IBM SPSS Statistics Base 20. SPSS Inc., Chicago; 2011.
[23] Guimarães LM, da Costa Carneiro EL, Carvalho-Costa FA. Increasing incidence of pertussis in Brazil: a retrospective study using surveillance data. BMC infectious diseases. 2015 Dec;15(1):442.
[24] Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Pertussis: microbiology, disease, treatment, and prevention. Clinical microbiology reviews. 2016 Jul 1;29(3):449-86.
[25] Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. The Pediatric infectious disease journal. 2005 May 1;24(5):S58-61.
[26] Thisyakorn U, Tantawichien T, Thisyakorn C, Buchy P. Pertussis in the Association of Southeast Asian Nations: epidemiology and challenges. International Journal of Infectious Diseases. 2019 Oct 1;87:75-83.
[28] Datta SS, Toikilik S, Ropa B, Chidlow G, Lagani W. Pertussis outbreak in Papua New Guinea: the challenges of response in a remote geo-topographical setting. Western Pacific surveillance and response journal: WPSAR. 2012 Oct;3(4):3.
[29] Soofie N, Nunes MC, Kgagudi P, van Niekerk N, Makgobo T, Agosti Y, Hwinya C, Pathirana J, Madhi SA: The Burden of Pertussis Hospitalization in HIV-Exposed and HIV-Unexposed South African Infants. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016, 63(suppl 4):S165-s173.
[30] Barger-Kamate B, Deloria Knoll M, Kagucia EW, Prosperi C, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Howie SR, Levine OS et al: Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016, 63(suppl 4):S187-s196.
[31] Drug Administration and Control Authority of Ethiopia (DACAE). Standard treatment guideline for health centers. 2010 Addis Ababa DACAE.
[32] Theodoridou M, Hadjipanagis A, Persianis N, Makri S, Hadjichristodoulou C. Pertussis outbreak detected by active surveillance in Cyprus in 2003. Eurosurveillance. 2007 May 1;12(5):11-2.
[33] Dellepiane N, Pagliusi S, Registration Experts Working Group. Challenges for the registration of vaccines in emerging countries: Differences in dossier requirements, application and evaluation processes. Vaccine. 2018 Jun 7;36(24):3389-96.
[34] Craig AT, Joshua CA, Sio AR, Lauri M, Kaldor J, Rosewell AE, Schierhout G. Towards effective outbreak detection: a qualitative study to identify factors affecting nurses’ early warning surveillance practice in Solomon Islands. BMC health services research. 2018 Dec;18(1):702.
[35] Endriyas M, Solomon T, Belayhun B, Mekonnen E. Poor quality data challenges conclusion and decision making: timely analysis of measles confirmed and suspected cases line list in Southern Nations Nationalities and People’s Region, Ethiopia. BMC infectious diseases. 2018 Dec;18(1):77.
[36] Patriarca PA, Biellik RJ, Sanden GA, Burstyn DG, Mitchell PD, Silverman PR, Davis JP, Manclark CR. Sensitivity and specificity of clinical case definitions for pertussis. American Journal of Public Health. 1988 Jul;78(7):833-6.
[37] Guiso N, Taieb F. Pertussis in Low and Medium Income Countries: A Pragmatic Approach. In: Fedele G., Ausiello C. (eds) Pertussis Infection and Vaccines. Advances in Experimental Medicine and Biology, Springer, Cham. 2019; vol 1183: 137 -149.